Company: INMB
Filing Date: 2025-05-09
Form Type: DEFR14A
Source: 0001213900-25-041516
Chunk: 0

Company: Inmune Bio, Inc.
Filing Date: 2025-05-09
Form: DEFR14A
Chunk 0
---
<div align='center'>UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

(Amendment No. 1)

Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934, as Amended</div>

Filed by the Registrant ☒

Filed by a Party other than the Registrant ☐

Check the appropriate box:

| ☐ | Preliminary Proxy Statement                                                     |
| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| ☒ | Definitive Proxy Statement                                                      |
| ☐ | Definitive Additional Materials                                                 |
| ☐ | Soliciting Material under Section 240.14a-12                                    |

<div align='center'>INmune Bio Inc.

(Name of Registrant as Specified in its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)</div>

Payment of Filing Fee (Check the appropriate box):

| ☒ | No fee required                                                                                      |
| ☐ | Fee paid previously with preliminary materials:                                                      |
| ☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. |

<div align='center'>INmune Bio Inc.</div>

Dear Stockholder:

On May 7, 2025, we dismissed Marcum LLP as our
independent registered public accounting firm, not as a result of any disagreement on any matter of accounting principles or practices,
financial statement disclosure, or audit scope or procedure and appointed CBIZ CPAs P.C. (“CBIZ CPAs”). We are enclosing herewith
Amendment No. 1 to Schedule 14A (“Amendment No. 1”), filed with the U.S. Securities and Exchange Commission (the “SEC”)
on May 9, 2025, which amends Proposal No. 2 (“Proposal No. 2”) of our original definitive proxy statement on Schedule 14A,
as filed with the SEC on April 21, 2025 (the “Original Definitive Proxy Statement”), as supplemented by the proxy supplement
to our Original Definitive Proxy Statement (together, with the Original Definitive Proxy Statement, the “Definitive Proxy Statement”),
as filed with the SEC on April 25, 2025